No Data
We Think C-MER Medical Holdings (HKG:3309) Can Manage Its Debt With Ease
Positive Earnings Growth Hasn't Been Enough to Get C-MER Medical Holdings (HKG:3309) Shareholders a Favorable Return Over the Last Three Years
C-MER MEDICAL: 2024 INTERIM REPORT
C-MER Medical Chairman Bolsters Shareholding
Express News | C-Mer Medical Holdings - on Sept 12, Chairman Purchased 1.2 Mln Shares of Co for HK$2.4 Mln
Hima Medical (03309.HK) received an increase in shareholding of 1.004 million shares from Chairman, CEO and Executive Director Lin Shunchao.
According to the latest equity disclosure information from the Hong Kong Stock Exchange, from September 12th to September 16th, 2024, Xima Medical (03309.HK) chairman, CEO and executive director Lin Shunchao purchased a total of 1.004 million shares at an average price of HK$2.0308-2.0571 per share, with a total investment of approximately HK$2.05 million. After the shareholding, Lin Shunchao's latest shareholding is 691,616,553 shares, and the shareholding ratio has increased from 55.00% to 55.08%.
C-MER Eye Care Holdings (HKG:3309 Investor Three-year Losses Grow to 49% as the Stock Sheds HK$449m This Past WeekNo Data
No Data
